Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Relay Therapeutics, Inc.(RLAY) | 12,000,000 | 12,000,000 | 0 | $224.52M | $216.60M | 16.78% | -$7.92M |
| Enliven Therapeutics Inc | 3,275,000 | 3,275,000 | 0 | $166.21M | $150.13M | 11.63% | -$16.08M |
| Alkermes plcSHS(ALKS) | 3,000,000 | 2,875,360 | -124,640 | $157.19M | $116.51M | 9.03% | -$40.68M |
| Alto Neuroscience, Inc.(ANRO) | 2,723,196 | 2,723,196 | 0 | $71.87M | $69.52M | 5.39% | -$2.34M |
| Spyre Therapeutics, Inc.(SYRE) | 846,786 | 700,000 | -146,786 | $75.18M | $62.32M | 4.83% | -$12.86M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 5,650,000 | 2,000,000 | -3,650,000 | $101.47M | $58.20M | 4.51% | -$43.27M |
| LB Pharmaceuticals Inc(LBRX) | 1,500,000 | 1,282,273 | -217,727 | $48.68M | $49.21M | 3.81% | +$531.1K |
| Damora Therapeutics Inc | 0 | 1,939,000 | +1,939,000 | $0 | $41.26M | 3.20% | +$41.26M |
| Cogent Biosciences, Inc.(COGT) | 3,050,000 | 1,265,000 | -1,785,000 | $118.03M | $40.51M | 3.14% | -$77.53M |
| Tyra Biosciences, Inc.(TYRA) | 1,875,000 | 1,725,000 | -150,000 | $59.89M | $37.73M | 2.92% | -$22.16M |
| Celldex Therapeutics, Inc.(CLDX) | 1,350,000 | 1,000,000 | -350,000 | $50.23M | $32.41M | 2.51% | -$17.82M |
| Pharvaris N V COM | 1,425,000 | 925,000 | -500,000 | $49.28M | $29.34M | 2.27% | -$19.94M |
| Surrozen, Inc.(SRZN) | 0 | 885,000 | +885,000 | $0 | $28.48M | 2.21% | +$28.48M |
| Korsana Biosciences Inc | 0 | 877,022 | +877,022 | $0 | $28.06M | 2.17% | +$28.06M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 0 | 2,757,742 | +2,757,742 | $0 | $27.25M | 2.11% | +$27.25M |
| Definium Therapeutics, Inc.(DFTX) | 2,000,000 | 700,000 | -1,300,000 | $94.08M | $26.64M | 2.06% | -$67.44M |
| Adarx Pharmaceuticals Inc | 0 | 1,260,577 | +1,260,577 | $0 | $25.14M | 1.95% | +$25.14M |
| Editas Medicine, Inc.(EDIT) | 8,889,000 | 8,889,000 | 0 | $28.80M | $22.84M | 1.77% | -$5.96M |
| Entera Bio Ltd.SHS(ENTX) | 0 | 7,352,941 | +7,352,941 | $0 | $21.40M | 1.66% | +$21.40M |
| Attovia Therapeutics Inc | 0 | 1,160,000 | +1,160,000 | $0 | $19.88M | 1.54% | +$19.88M |
| Agenus Inc.(AGEN) | 0 | 1,985,387 | +1,985,387 | $0 | $19.71M | 1.53% | +$19.71M |
| Kymera Therapeutics, Inc.(KYMR) | 250,000 | 175,000 | -75,000 | $28.67M | $19.56M | 1.52% | -$9.10M |
| InflaRx N.V.(IFRX) | 7,300,000 | 9,268,220 | +1,968,220 | $16.35M | $16.68M | 1.29% | +$330.8K |
| Avalo Therapeutics, Inc.(AVTX) | 1,018,319 | 1,018,319 | 0 | $18.82M | $15.61M | 1.21% | -$3.21M |
| An2 Therapeutics Inc | 2,933,680 | 2,933,680 | 0 | $14.20M | $15.61M | 1.21% | +$1.41M |
| Century Therapeutics, Inc.(IPSC) | 8,695,652 | 8,695,652 | 0 | $21.30M | $14.87M | 1.15% | -$6.43M |
| Zura Bio LimitedCL A(ZURA) | 3,250,000 | 3,250,000 | 0 | $19.18M | $13.52M | 1.05% | -$5.66M |
| Inhibikase Therapeutics, Inc.(IKT) | 5,397,488 | 5,397,488 | 0 | $10.96M | $11.09M | 0.86% | +$134.9K |
| Assembly Biosciences Inc | 1,415,000 | 461,922 | -953,078 | $38.88M | $10.85M | 0.84% | -$28.03M |
| PepGen Inc.(PEPG) | 4,475,000 | 4,475,000 | 0 | $8.05M | $10.83M | 0.84% | +$2.77M |
| SAB Biotherapeutics, Inc.(SABS) | 2,870,000 | 2,870,000 | 0 | $11.19M | $9.10M | 0.70% | -$2.10M |
| Relmada Therapeutics, Inc.(RLMD) | 1,425,000 | 2,350,000 | +925,000 | $9.86M | $8.86M | 0.69% | -$1.00M |
| Research Alliance Corp IvCL A | 0 | 500,000 | +500,000 | $0 | $5.79M | 0.45% | +$5.79M |
| Helix Acquisition Corp. IIICL A(HLXC) | 500,000 | 500,000 | 0 | $5.32M | $5.31M | 0.41% | -$10.0K |
| Jatt Iii Acquisition Corp | 0 | 400,000 | +400,000 | $0 | $4.41M | 0.34% | +$4.41M |
| Tcgx Acquisition CorpCL A | 0 | 300,000 | +300,000 | $0 | $3.75M | 0.29% | +$3.75M |
| LeonaBio, Inc.(LONA) | 464,398 | 464,398 | 0 | $4.27M | $1.66M | 0.13% | -$2.61M |
| Damora Therapeutics, Inc.(DMRA) | 1,939,000 | 0 | -1,939,000 | $50.43M | $0 | — | -$50.43M |
| EyePoint, Inc.(EYPT) | 4,600,000 | 0 | -4,600,000 | $65.78M | $0 | — | -$65.78M |
| Nuvalent Inc | 100,000 | 0 | -100,000 | $12.35M | $0 | — | -$12.35M |
| Perspective Therapeutics, Inc.(CATX) | 6,336,782 | 0 | -6,336,782 | $21.61M | $0 | — | -$21.61M |
| Research Alliance Corp IiiCL A | 500,000 | 0 | -500,000 | $5.35M | $0 | — | -$5.35M |
| Tango Therapeutics, Inc.(TNGX) | 2,250,000 | 0 | -2,250,000 | $70.33M | $0 | — | -$70.33M |
| Vistagen Therapeutics, Inc.(VTGN) | 2,788,620 | 0 | -2,788,620 | $630.2K | $0 | — | -$630.2K |